Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

A unique case of chronic myeloid leukemia presenting as monocular vision loss with unilateral retinopathy.

Seraly MP, Gupta SK, Mehmi I, Veltri L, Ghorayeb GR.

Am J Ophthalmol Case Rep. 2019 Feb 15;14:67-69. doi: 10.1016/j.ajoc.2019.02.003. eCollection 2019 Jun.

2.

Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report.

Richardson DR, Ellis B, Mehmi I, Leys M.

Int J Ophthalmol. 2017 Jul 18;10(7):1183-1186. doi: 10.18240/ijo.2017.07.28. eCollection 2017. No abstract available.

3.

Metastatic Sarcomatoid Carcinoma of the Small Intestine: a Case Report of Rare Tumor with Literature Review.

Khelfa Y, Alsharedi M, Mehmi I, Raufi A, Arrington A, Lebowicz Y, Pacioles T.

J Gastrointest Cancer. 2016 Dec;47(4):478-481. Review. No abstract available.

PMID:
26545611
4.

Endogenous aryl hydrocarbon receptor promotes basal and inducible expression of tumor necrosis factor target genes in MCF-7 cancer cells.

Salisbury TB, Tomblin JK, Primerano DA, Boskovic G, Fan J, Mehmi I, Fletcher J, Santanam N, Hurn E, Morris GZ, Denvir J.

Biochem Pharmacol. 2014 Oct 1;91(3):390-9. doi: 10.1016/j.bcp.2014.06.015. Epub 2014 Jun 24.

5.
7.
9.

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.

Menendez JA, Vellon L, Mehmi I, Oza BP, Ropero S, Colomer R, Lupu R.

Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10715-20. Epub 2004 Jul 2.

13.

Black cohosh, a menopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth.

Lupu R, Mehmi I, Atlas E, Tsai MS, Pisha E, Oketch-Rabah HA, Nuntanakorn P, Kennelly EJ, Kronenberg F.

Int J Oncol. 2003 Nov;23(5):1407-12.

PMID:
14532983
14.

The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.

Menéndez JA, Mehmi I, Griggs DW, Lupu R.

Endocr Relat Cancer. 2003 Jun;10(2):141-52. Review.

PMID:
12790776
15.
16.

Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer.

Tsai MS, Shamon-Taylor LA, Mehmi I, Tang CK, Lupu R.

Oncogene. 2003 Feb 6;22(5):761-8.

PMID:
12569369
17.

Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.

Atlas E, Cardillo M, Mehmi I, Zahedkargaran H, Tang C, Lupu R.

Mol Cancer Res. 2003 Jan;1(3):165-75.

18.

Expression and regulation of Cyr61 in human breast cancer cell lines.

Tsai MS, Bogart DF, Li P, Mehmi I, Lupu R.

Oncogene. 2002 Jan 31;21(6):964-73.

Supplemental Content

Support Center